site banner

Eli Lilly releases data for a new weight-loss drug to tackle obesity : Shots - Health News : NPR

npr.org

This drug is a true gamechanger

In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.

this is comparable to bariatric surgery

11
Jump in the discussion.

No email address required.

A good look at the picture I'm using here will reveal roughly what the answer is.

I'm afraid I don't see what you're getting at; can you explain more clearly?

When your comment is this opaque and low effort, it's probably a bad comment.

I'm afraid I don't.

It's dilemma. Either be too personal or just eat the downvotes.

I'll eat the downvotes, I guess.